Diet & Nutrition News and Research

Latest Diet & Nutrition News and Research

FG-2216 drug offers new treatment option for kidney disease-related anemia

A new drug called FG-2216 can stimulate production of the hormone erythropoietin (EPO) in dialysis patients—possibly offering a new approach to treatment of kidney disease-related anemia, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

30 Nov 2010

New study may lead to non-medicinal methods of eradicating Hamburger disease

Hamburger disease, a debilitating form of food poisoning, may be a thing of the past. New findings from an international research collaboration conducted by the French National Institute for Agronomic Research (INRA), involving the Universit- de Montr-al are the first to show how the contaminating E.coli bacterium is able to survive in the competitive environment of a cow's intestine by scavenging specific food sources.

30 Nov 2010

Tips to encourage children to eat vegetables, fruits

In a new study, children who ate the most vegetables and fruits had significantly healthier arteries as adults than children who ate the fewest. Here are 10 tips to encourage your children to eat more vegetables and fruits.

30 Nov 2010

IOM report updates DRIs levels of Vitamin D, calcium

Vitamin D and calcium have been the focus of much research since the Institute of Medicine set nutritional reference values for them in 1997. Known as Dietary Reference Intakes, the values for these and other nutrients serve as a guide for good nutrition and provide the scientific basis for the development of food guidelines in both the United States and Canada. Updated DRIs for these two nutrients are presented in a new IOM report, Dietary Reference Intakes for Calcium and Vitamin D, which will be released on Tuesday, Nov. 30.

30 Nov 2010

Long-term phase 3 trial confirms safety of lubiprostone in Japanese patients with chronic idiopathic constipation

Sucampo Pharmaceuticals, Inc. and Abbott today announced positive top-line data from a 48-week phase 3 long-term safety and efficacy clinical trial of lubiprostone in Japanese patients with chronic idiopathic constipation (CIC). The trial demonstrated that lubiprostone was safe and well-tolerated.

30 Nov 2010

APP to launch Topotecan for Injection following FDA marketing approval

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately.

30 Nov 2010

New tool to trace metabolism of carotenoids in human body

The University of Illinois scientists who linked eating tomatoes with a reduced risk of prostate cancer have developed a tool that will help them trace the metabolism of tomato carotenoids in the human body. And they've secured funding from the National Institutes of Health to do it.

30 Nov 2010

Study finds abdominal fat as a risk factor for osteoporosis, bone loss in women

For years, it was believed that obese women were at lower risk for developing osteoporosis, and that excess body fat actually protected against bone loss. However, a study presented today at the annual meeting of the Radiological Society of North America (RSNA) found that having too much internal abdominal fat may, in fact, have a damaging effect on bone health.

30 Nov 2010

Queenslanders fatter but live longer and smoke less: Health report

A new health report reveals that more than 60 per cent of Queensland adults are overweight or obese. The Health of Queenslanders report also reveals that Queenslanders are living longer and smoking less.

29 Nov 2010

MEDRAD launches VirtualCARE solution for Intego PET Infusion System

MEDRAD, Inc. a business of Bayer HealthCare, today announces the U.S. launch of VirtualCARE®, for the MEDRAD Intego™ PET Infusion System. VirtualCARE is a technology platform that allows MEDRAD to remotely support maintenance and system updates securely over the internet.

29 Nov 2010

DK Sinopharma third quarter sales increase 66% to $7,290,685

DK Sinopharma, Inc., announced its third quarter 2010 financial results. The Company's quarterly report on Form 10-Q was filed with the U.S. Securities & Exchange Commission on November 22, 2010.

29 Nov 2010

3SBio acquires pegsiticase global rights from EnzymeRx for $6.25 million

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announced that is has acquired worldwide rights of pegsiticase for all indications from EnzymeRx for a total consideration of US$6.25 million.

29 Nov 2010

Amarin reports top-line results from AMR101 Phase 3 trial for treatment of high triglycerides

Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reported positive, statistically significant top-line results from the MARINE study, its first Phase 3 clinical trial of lead drug candidate AMR101.

29 Nov 2010

Overexposure to triclosan may negatively influence immune system: Study

Young people who are overexposed to antibacterial soaps containing triclosan may suffer more allergies, and exposure to higher levels of Bisphenol A among adults may negatively influence the immune system, a new University of Michigan School of Public Health study suggests.

29 Nov 2010

Alpha carotene increase life span: Study

A new study shows that and antioxidant alpha carotene found in vegetables can reduce the risk of premature death and allow for a longer, healthier lifespan. The study led by Dr. Chaoyang Li from the U.S. Centers for Disease Control and Prevention (CDC) involved nearly 15,000 adults who were all age 20 and older. It spanned over 1988 to 1994, with patients being followed-up with in the year 2006. The plan was to look at the effect of an antioxidants found in vegetables on the health of people.

28 Nov 2010

Neptune, Acasti completes preclinical program comparing CaPre with Lovaza

Neptune Technologies & Bioressources Inc. subsidiary, Acasti Pharma Inc., reports the completion of its preclinical program designed to compare the lipid management effects of Acasti's drug candidate CaPre versus prescription drug Lovaza.

25 Nov 2010

Immunity-enhancing probiotics may be the best line of defense for good health

Good bacteria, bad bacteria, billions of bacteria—sounds downright germy. But the truth is that research in gut health is germinating more insight into the role bacteria, also known as "probiotics," play in our overall health and wellness.

25 Nov 2010

DSM wins Most Innovative Health Ingredient Award

DSM Nutritional Products triumphed at this year's HiE Excellence Awards with Fruitflow® - the first natural, scientifically substantiated solution for the promotion of healthy blood flow. As well as winning the Most Innovative Health Ingredient Award, DSM also won an Excellence Award in the category of Heart Health.

25 Nov 2010

Diogenes study investigates optimum diet composition for preventing, treating obesity

Researchers at the Faculty of Life Sciences (LIFE), University of Copenhagen, can now unveil the results of the world's largest diet study: If you want to lose weight, you should maintain a diet that is high in proteins with more lean meat, low-fat dairy products and beans and fewer finely refined starch calories such as white bread and white rice.

25 Nov 2010

USAID's Shah announces Bureau for Food Security; Bread for the World releases 2011 Hunger Report

USAID Administrator Rajiv Shah announced on Monday the creation of a Bureau for Food Security within the agency "to manage the Obama administration's Feed the Future initiative, which Secretary of State Hillary Rodham Clinton plans to turn over to USAID," National Journal Daily reports.

25 Nov 2010